SMTL ID : 6f78.1 (1 other biounit)

Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.30 Å

Oligo State

monomer

Ligands

1 x CVN: 4-[[3,5-bis(trifluoromethyl)phenyl]amino]-1,2-benzoxazol-3-one(Non-covalent)

CVN.1: 14 residues within 4Å: Chain A: Y.19, L.49, Y.50, W.81, H.112, S.113, M.115, N.162, Y.211, W.222, F.301, S.303, F.306 Ligands: NAP.3 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.81, A:F.301, A:F.301, A:F.301 Hydrogen bonds: A:Y.50, A:Y.50, A:H.112 pi-Stacking: A:Y.19

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: H.48, N.51, K.100 Ligand excluded by PLIP

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.3: 29 residues within 4Å: Chain A: G.17, T.18, Y.19, D.45, Y.50, K.79, H.112, S.161, N.162, Q.185, Y.211, S.212, A.213, L.214, G.215, S.216, Q.217, L.231, A.248, L.263, A.264, K.265, S.266, Y.267, N.268, R.271, Q.274, N.275 Ligands: CVN.1 26 PLIP interactions: 26 interactions with chain A Hydrogen bonds: A:T.18, A:Y.19, A:D.45, A:S.161, A:N.162, A:Q.185, A:S.212, A:L.214, A:S.216, A:Q.217, A:Q.217, A:Q.217, A:K.265, A:S.266, A:Y.267, A:Q.274, A:N.275 Water bridges: A:S.212, A:A.213, A:A.213, A:Q.274, A:Q.274 Salt bridges: A:K.265, A:R.271 pi-Stacking: A:Y.211 pi-Cation interactions: A:R.271

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pippione, A.C. et al., Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid. Eur J Med Chem (2018)

Release Date

2018-04-04

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence